164 related articles for article (PubMed ID: 29987129)
21. Rectal carcinoma and multiple gastrointestinal stromal tumors (GIST) of the small intestine in a patient with neurofibromatosis type 1: a case report.
Hakozaki Y; Sameshima S; Tatsuoka T; Okuyama T; Yamagata Y; Noie T; Oya M; Fujii A; Ueda Y; Shimura C; Katagiri K
World J Surg Oncol; 2017 Aug; 15(1):160. PubMed ID: 28835241
[TBL] [Abstract][Full Text] [Related]
22. Hyaluronan in intra-operative edema of NF1-associated neurofibromas.
Hagel C; Behrens T; Prehm P; Schnabel C; Glatzel M; Friedrich RE
Neuropathology; 2012 Aug; 32(4):406-14. PubMed ID: 22129111
[TBL] [Abstract][Full Text] [Related]
23. Clinical assessment of the use of topical liquid diclofenac following laser microporation of cutaneous neurofibromas in individuals with neurofibromatosis type 1.
Oliveira LB; Geller M; Cunha KS; Santos A; Bernacchi A; Rubenstein AE; Takirambudde S; Mezitis S; de Almeida Ito Brum C; Darrigo LG; Ribeiro MG
Heliyon; 2021 Mar; 7(3):e06518. PubMed ID: 33817379
[TBL] [Abstract][Full Text] [Related]
24. The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1.
Well L; Jaeger A; Kehrer-Sawatzki H; Farschtschi S; Avanesov M; Sauer M; de Sousa MT; Bannas P; Derlin T; Adam G; Mautner VF; Salamon JM
PLoS One; 2020; 15(4):e0232031. PubMed ID: 32343738
[TBL] [Abstract][Full Text] [Related]
25. Floret-like multinucleated giant cells in a neurofibromatosis type 1-associated neurofibroma.
Swick BL
Am J Dermatopathol; 2008 Dec; 30(6):632-4. PubMed ID: 19033946
[TBL] [Abstract][Full Text] [Related]
26. Cellular Origin, Tumor Progression, and Pathogenic Mechanisms of Cutaneous Neurofibromas Revealed by Mice with
Radomska KJ; Coulpier F; Gresset A; Schmitt A; Debbiche A; Lemoine S; Wolkenstein P; Vallat JM; Charnay P; Topilko P
Cancer Discov; 2019 Jan; 9(1):130-147. PubMed ID: 30348676
[TBL] [Abstract][Full Text] [Related]
27. Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study.
Cannon A; Chen MJ; Li P; Boyd KP; Theos A; Redden DT; Korf B
Orphanet J Rare Dis; 2018 Feb; 13(1):31. PubMed ID: 29415745
[TBL] [Abstract][Full Text] [Related]
28. A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening.
Nguyen HTL; Kohl E; Bade J; Eng SE; Tosevska A; Al Shihabi A; Tebon PJ; Hong JJ; Dry S; Boutros PC; Panossian A; Gosline SJC; Soragni A
Cell Rep Methods; 2024 May; 4(5):100772. PubMed ID: 38744290
[TBL] [Abstract][Full Text] [Related]
29. Melanocytic nevi are associated with neurofibromas in neurofibromatosis, type I, but not sporadic neurofibromas: a study of 226 cases.
Ball NJ; Kho GT
J Cutan Pathol; 2005 Sep; 32(8):523-32. PubMed ID: 16115049
[TBL] [Abstract][Full Text] [Related]
30. Treatment of Cutaneous Neurofibromas in Patients with Neurofibromatosis Type 1.
Wozniak B; Bove T; Zawada T; Calik J
Case Rep Dermatol; 2023; 15(1):194-201. PubMed ID: 37899948
[TBL] [Abstract][Full Text] [Related]
31. Losses in chromosomes 17, 19, and 22q in neurofibromatosis type 1 and sporadic neurofibromas: a comparative genomic hybridization analysis.
Koga T; Iwasaki H; Ishiguro M; Matsuzaki A; Kikuchi M
Cancer Genet Cytogenet; 2002 Jul; 136(2):113-20. PubMed ID: 12237234
[TBL] [Abstract][Full Text] [Related]
32. Topical sirolimus as an effective treatment for a deep neurofibroma in a patient with neurofibromatosis type I.
Malhotra N; Levy JMS; Fiorillo L
Pediatr Dermatol; 2019 May; 36(3):360-361. PubMed ID: 30828862
[TBL] [Abstract][Full Text] [Related]
33. Natural course and characteristics of cutaneous neurofibromas in neurofibromatosis 1.
Ehara Y; Yamamoto O; Kosaki K; Yoshida Y
J Dermatol; 2018 Jan; 45(1):53-57. PubMed ID: 28891076
[TBL] [Abstract][Full Text] [Related]
34. Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth.
Well L; Döbel K; Kluwe L; Bannas P; Farschtschi S; Adam G; Mautner VF; Salamon J
PLoS Genet; 2021 May; 17(5):e1009517. PubMed ID: 33951044
[TBL] [Abstract][Full Text] [Related]
35. C2 neurofibromas in neurofibromatosis type 1: genetic and imaging characteristics.
Waqar M; Huson S; Evans DG; Ealing J; Karabatsou K; George KJ; Soh C
J Neurosurg Spine; 2018 Oct; 30(1):126-132. PubMed ID: 30485203
[TBL] [Abstract][Full Text] [Related]
36. Heightened CXCR4 and CXCL12 expression in NF1-associated neurofibromas.
Karaosmanoglu B; Kocaefe ÇY; Söylemezoğlu F; Anlar B; Varan A; Vargel İ; Ayter S
Childs Nerv Syst; 2018 May; 34(5):877-882. PubMed ID: 29455242
[TBL] [Abstract][Full Text] [Related]
37. Thyroid gland neurofibroma in a NF1 patient.
Anagnostouli M; Piperingos G; Yapijakis C; Gourtzelidis P; Balafouta S; Zournas C; Vassilopoulos D; Koutras D; Papageorgiou C
Acta Neurol Scand; 2002 Jul; 106(1):58-61. PubMed ID: 12067331
[TBL] [Abstract][Full Text] [Related]
38. Neurofibromatosis type 1: Factors associated with flare-ups of cutaneous neurofibromas at puberty.
Skayem C; Fertitta L; Diaz E; Jannic A; Ferkal S; Ravaud P; Tran VT; Ezzedine K; Wolkenstein P
J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):e158-e159. PubMed ID: 36226401
[No Abstract] [Full Text] [Related]
39. Mast Cells in Human Cutaneous Neurofibromas: Density, Subtypes, and Association with Clinical Features in Neurofibromatosis 1.
Kallionpää RA; Ahramo K; Martikkala E; Fazeli E; Haapaniemi P; Rokka A; Leivo I; Harvima IT; Peltonen J; Peltonen S
Dermatology; 2022; 238(2):329-339. PubMed ID: 34237737
[TBL] [Abstract][Full Text] [Related]
40. Association of urticaria pigmentosa with café-au-lait spots, neurofibromas and neurofibroma-like neoplasms: a mere coincidence?
Möhrenschlager M; Engst R; Müller-Weihrich S; Spiessl W; Rüdisser K; Weigl LB; Jessberger B; Braun-Falco M; Abeck D; Ring J
Dermatology; 2003; 206(4):297-302. PubMed ID: 12771469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
